Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
National Institutes of Health Clinical Center (CC)
University of Miami